US2013189749A1PendingUtilityA1
Compositions, Methods, and Kits for Polyunsaturated Fatty Acids from Microalgae
Assignee: WAKE FOREST UNIVERSITY SCHOOL OF MEDICINEPriority: Nov 1, 2007Filed: Dec 28, 2012Published: Jul 25, 2013
Est. expiryNov 1, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61P 3/06A61P 37/08A61P 29/00A61P 11/06C07C 51/48Y02A40/818A61K 36/04A23K 50/10C11B 1/10A61K 36/02C12N 15/79A61K 36/30A23K 20/158A23K 50/80A61K 31/20C12P 7/6427C12P 7/6432C12P 7/6434
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions, methods, and kits comprising PUFAs produced by microalgae, in particular omega-3 and/or omega-6 fatty acids produced by members of the genus Rhodomonas , in particular Rhodomonas salina . The invention also provides compositions, methods, and kits comprising the PUFAs for the prophylactic and/or therapeutic treatment of a disease or condition, in particular a cardiovascular and/or inflammatory disease or condition.
Claims
exact text as granted — not AI-modified1 .- 80 . (canceled)
81 . An isolated genetically modified variant Rhodomonas strain comprising at least one heterologous nucleic acid encoding an enzyme selected from the group consisting of a fatty acid synthase, a desaturase, and an elongase, wherein said strain exhibits increased polyunsaturated fatty acid levels relative to strains lacking said heterologous nucleic acids.
82 . The Rhodomonas strain of claim 81 , wherein said nucleic acid encodes a fatty acid synthase.
83 . The Rhodomonas strain of claim 81 , wherein said nucleic acid encodes a desaturase.
84 . The Rhodomonas strain of claim 81 , wherein said nucleic acid encodes an elongase.
85 . The strain as claimed in claim 81 to claim 84 , which is ATCC No. PTA-9989.
86 . A process of making a polyunsaturated fatty acid (PUFA) composition comprising at least 8% polyunsaturated fatty acids in weight, the process comprising: extracting the polyunsaturated fatty acids from the microalgae of claim 81 , wherein,
(a) SDA is in an amount of about 5% to about 50% of total fatty acids; (b) EPA is in an amount of about 2% to about 40% of total fatty acids; (c) DHA is in an amount of about 2% to about 40% of total fatty acids; and optionally (d) GLA is in an amount of about 0.1% to about 10% of total fatty acids; wherein the composition comprises at least 8% polyunsaturated fatty acids in weight.
87 . The process of claim 86 , wherein the microalgae is a microalgae having a cell wall of reduced thickness as compared to the wild-type microalgae, wherein said cell wall of reduced thickness improves extractability and/or bioavailability of the microalgae lipid fraction.
88 . A process of making a composition comprising at least 5% stearidonic acid, the process comprising:
(a) cultivating the microalgae of claim 81 to produce a microalgae biomass; and either (b) extracting said microalgae oil from said cultivated microalgae; or (c) removing water from said microalgae biomass to achieve a solids content from 5 to 100% weight percent; wherein the composition comprises at least 5% stearidonic acid.
89 . A method for preparing a microalgae biomass composition comprising one or more PUFAs, the method comprising: culturing a microalgae of claim 81 under a culture condition sufficient to provide a microalgae biomass comprising the one or more PUFAs, wherein the microalgae biomass is harvested after at least one logarithmic growth phase of the microalgae, wherein the omega-3 fatty acid is stearidonic acid (SDA), wherein the omega-6 fatty acid is γ-linolenic acid (GLA), wherein the SDA at harvest is at least about 5% of the total fatty acid, wherein the GLA at harvest is less than about 1% of total fatty acid.
90 . A biologically pure culture of the isolated Rhodomonas of claim 85 .
91 . A method for preparing a microalgae biomass composition comprising one or more PUFAs, the method comprising: culturing a microalgae of claim 90 under a culture condition sufficient to provide a microalgae biomass comprising the one or more PUFAs, wherein the microalgae biomass is harvested after at least one logarithmic growth phase of the microalgae, wherein the omega-3 fatty acid is stearidonic acid (SDA), wherein the omega-6 fatty acid is optionally present and is γ-linolenic acid (GLA), wherein the SDA at harvest is at least about 5% of the total fatty acid, wherein the GLA if present at harvest is less than about 1% of total fatty acid.
92 . A method for preparing a microalgae biomass composition comprising at least 8% polyunsaturated fatty acids in weight, the method comprising: culturing a microalgae of claim 90 the process comprising: extracting the polyunsaturated fatty acids from the microalgae, wherein,
(a) SDA is in an amount of about 5% to about 50% of total fatty acids;
(b) EPA is in an amount of about 2% to about 40% of total fatty acids;
(c) DHA is in an amount of about 2% to about 40% of total fatty acids; and optionally
(d) GLA is in an amount of about 0.1% to about 10% of total fatty acids; wherein the composition comprises at least 8% polyunsaturated fatty acids in weight.
93 . An isolated mixed culture of microalgae and bacteria, wherein said micro algae is genetically modified.Join the waitlist — get patent alerts
Track US2013189749A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.